Audentes Therapeutics (BOLD) Tops Q3 EPS by 1c
Get Alerts BOLD Hot Sheet
Join SI Premium – FREE
Audentes Therapeutics (NASDAQ: BOLD) reported Q3 EPS of ($0.88), $0.01 better than the analyst estimate of ($0.89).
For earnings history and earnings-related data on Audentes Therapeutics (BOLD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rexford Industrial Realty (REXR) Reports In-Line Q1 EPS, provides guidance
- Triumph Financial, Inc. (TFIN) Misses Q1 EPS by 20c
- Old Second Bancorp (OSBC) Reports In-Line Q1 EPS
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!